BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38103659)

  • 1. Impact of amino acid substitutions in hepatitis C virus core region on the severe oxidative stress.
    Chida T; Watanabe S; Ohta K; Noritake H; Ito M; Suzuki T; Suda T; Kawata K
    Free Radic Biol Med; 2024 Feb; 212():199-206. PubMed ID: 38103659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency of Interferon-Resistance Conferring Substitutions in Amino Acid Positions 70 and 91 of Core Protein of the Russian HCV 1b Isolates Analyzed in the T-Cell Epitopic Context.
    Kichatova VS; Kyuregyan KK; Soboleva NV; Karlsen AA; Isaeva OV; Isaguliants MG; Mikhailov MI
    J Immunol Res; 2018; 2018():7685371. PubMed ID: 29577052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of amino acid substitutions in the hepatitis C virus genotype 1b core region on liver steatosis and hepatic oxidative stress in patients with chronic hepatitis C.
    Tachi Y; Katano Y; Honda T; Hayashi K; Ishigami M; Itoh A; Hirooka Y; Nakano I; Samejima Y; Goto H
    Liver Int; 2010 Apr; 30(4):554-9. PubMed ID: 19951380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Before Direct-Acting Antivirals for Hepatitis C Virus: Evaluation of Core Protein R70Q and L/C91M Substitutions in Chronically Infected Brazilian Patients Unresponsive to IFN and/or RBV.
    Campos LB; de Almeida NAA; de Santana CG; Barbosa ENP; Horta MAP; Amendola Pires M; Brandão Mello CE; de Paula VS; de Barros JJF
    Viruses; 2023 Jan; 15(1):. PubMed ID: 36680226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of interferon signaling by infectious hepatitis C virus clones with substitutions of core amino acids 70 and 91.
    Funaoka Y; Sakamoto N; Suda G; Itsui Y; Nakagawa M; Kakinuma S; Watanabe T; Mishima K; Ueyama M; Onozuka I; Nitta S; Kitazume A; Kiyohashi K; Murakawa M; Azuma S; Tsuchiya K; Watanabe M
    J Virol; 2011 Jun; 85(12):5986-94. PubMed ID: 21490101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of amino acid mutations in hepatitis C virus core and NS5B regions among Venezuelan viral isolates and comparison with worldwide isolates.
    Jaspe RC; Sulbarán YF; Sulbarán MZ; Loureiro CL; Rangel HR; Pujol FH
    Virol J; 2012 Sep; 9():214. PubMed ID: 22995142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon lambda and hepatitis C virus core protein polymorphisms associated with liver cancer.
    Moreira JP; Malta Fde M; Diniz MA; Kikuchi L; Chagas AL; Lima Lde S; Gomes-Gouvêa MS; de Castro VF; Santana RA; Sumita NM; Paranagua Vezozzo DC; Carrilho FJ; Pinho JR
    Virology; 2016 Jun; 493():136-41. PubMed ID: 27035616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amino acid substitutions in hepatitis C virus core region predict hepatocarcinogenesis following eradication of HCV RNA by antiviral therapy.
    Akuta N; Suzuki F; Hirakawa M; Kawamura Y; Sezaki H; Suzuki Y; Hosaka T; Kobayashi M; Kobayashi M; Saitoh S; Arase Y; Ikeda K; Kumada H
    J Med Virol; 2011 Jun; 83(6):1016-22. PubMed ID: 21503914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virological and biochemical features in elderly HCV patients with hepatocellular carcinoma: amino acid substitutions in HCV core region as predictor of mortality after first treatment.
    Ogura S; Akuta N; Hirakawa M; Kawamura Y; Yatsuji H; Sezaki H; Hosaka T; Kobayashi M; Suzuki F; Suzuki Y; Kobayashi M; Saitoh S; Arase Y; Ikeda K; Kumada H
    Intervirology; 2009; 52(4):179-88. PubMed ID: 19546575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complicated relationships of amino acid substitution in hepatitis C virus core region and IL28B genotype influencing hepatocarcinogenesis.
    Akuta N; Suzuki F; Seko Y; Kawamura Y; Sezaki H; Suzuki Y; Hosaka T; Kobayashi M; Hara T; Kobayashi M; Saitoh S; Arase Y; Ikeda K; Kumada H
    Hepatology; 2012 Dec; 56(6):2134-41. PubMed ID: 22806754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 8-Hydroxy-2'-deoxy-guanosine is a risk factor for development of hepatocellular carcinoma in patients with chronic hepatitis C virus infection.
    Chuma M; Hige S; Nakanishi M; Ogawa K; Natsuizaka M; Yamamoto Y; Asaka M
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1431-6. PubMed ID: 18854000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristic mutations in hepatitis C virus core gene related to the occurrence of hepatocellular carcinoma.
    Hu Z; Muroyama R; Kowatari N; Chang J; Omata M; Kato N
    Cancer Sci; 2009 Dec; 100(12):2465-8. PubMed ID: 20175782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Interferon Resistance in Newly Established Genotype 1b Hepatitis C Virus Cell Culture System.
    Taniguchi M; Tasaka-Fujita M; Nakagawa M; Watanabe T; Kawai-Kitahata F; Otani S; Goto F; Nagata H; Kaneko S; Nitta S; Murakawa M; Nishimura-Sakurai Y; Azuma S; Itsui Y; Mori K; Yagi S; Kakinuma S; Asahina Y; Watanabe M
    J Clin Transl Hepatol; 2016 Mar; 4(1):5-11. PubMed ID: 27047766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substitution of amino acid 70 in the hepatitis C virus core region of genotype 1b is an important predictor of elevated alpha-fetoprotein in patients without hepatocellular carcinoma.
    Akuta N; Suzuki F; Kawamura Y; Yatsuji H; Sezaki H; Suzuki Y; Hosaka T; Kobayashi M; Kobayashi M; Arase Y; Ikeda K; Kumada H
    J Med Virol; 2008 Aug; 80(8):1354-62. PubMed ID: 18551609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amino acid substitutions in the hepatitis C Virus core region and lipid metabolism are associated with hepatocarcinogenesis in nonresponders to interferon plus ribavirin combination therapy.
    Seko Y; Akuta N; Suzuki F; Kawamura Y; Sezaki H; Suzuki Y; Hosaka T; Kobayashi M; Kobayashi M; Saitoh S; Arase Y; Ikeda K; Kumada H
    Intervirology; 2013; 56(1):13-21. PubMed ID: 22907167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of hepatitis C virus core mutations on the response to interferon-based treatment in chronic hepatitis C.
    Sultana C; Oprişan G; Teleman MD; Dinu S; ; Oprea C; Voiculescu M; Ruta S
    World J Gastroenterol; 2016 Oct; 22(37):8406-8413. PubMed ID: 27729747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA methyltransferases 1 and 3b expression in Huh-7 cells expressing HCV core protein of different genotypes.
    Benegiamo G; Vinciguerra M; Mazzoccoli G; Piepoli A; Andriulli A; Pazienza V
    Dig Dis Sci; 2012 Jun; 57(6):1598-603. PubMed ID: 22526584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of amino-acid polymorphism in the core protein on progression of liver disease in patients infected with hepatitis C virus genotype 1b.
    Kobayashi M; Akuta N; Suzuki F; Hosaka T; Sezaki H; Kobayashi M; Suzuki Y; Arase Y; Ikeda K; Watahiki S; Mineta R; Iwasaki S; Miyakawa Y; Kumada H
    J Med Virol; 2010 Jan; 82(1):41-8. PubMed ID: 19950230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amino acid substitutions in the hepatitis C virus core region are the important predictor of hepatocarcinogenesis.
    Akuta N; Suzuki F; Kawamura Y; Yatsuji H; Sezaki H; Suzuki Y; Hosaka T; Kobayashi M; Kobayashi M; Arase Y; Ikeda K; Kumada H
    Hepatology; 2007 Nov; 46(5):1357-64. PubMed ID: 17657816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of amino acid substitutions in hepatitis C virus genotype 1b core region on liver steatosis and glucose tolerance in non-cirrhotic patients without overt diabetes.
    Sumida Y; Kanemasa K; Hara T; Inada Y; Sakai K; Imai S; Yoshida N; Yasui K; Itoh Y; Okanoue T; Yoshikawa T
    J Gastroenterol Hepatol; 2011 May; 26(5):836-42. PubMed ID: 21054524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.